Amgen Inc

Change company Symbol lookup

Select an option...

AMGN Amgen Inc

PCRFY Panasonic Holdings Corp

CRTD Creatd Inc

MSM MSC Industrial Direct Co Inc

FGEN FibroGen Inc

SUI Sun Communities Inc

HROWL HARROW HEALTH 8 625 SNR NTS

COF-I Capital One Financial Corp

VRAY ViewRay Inc

PEBC Peoples Bancorp Inc

Go

Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2022 financial results on Tuesday, Jan. 31, 2023, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the...(PR Newswire)

Biotherapeutics Company to Receive lab Space, Mentoring and Other Benefits Amgen (NASDAQ:AMGN) and BioLabs LA at The Lundquist Institute today announced that Nammi Therapeutics has been awarded the third Amgen Golden Ticket in Southern California...(PR Newswire)

Amgen (NASDAQ:AMGN) will present at the 2023 J.P. Morgan Healthcare Conference at 6:45 p.m. ET on Monday, January 9, 2023. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. The webcast will be broadcast...(PR Newswire)

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced a $25M milestone payment from Amgen (NASDAQ: AMGN). This milestone was triggered by the first subject enrolled in Amgen's Phase 3 trial of olpasiran. Arrowhead is further eligible to...(BusinessWire)

At 3.5 Years, 83% of Patients on BLINCYTO Plus Chemotherapy Were Alive Versus 65% of Patients on Chemotherapy Alone Trial Design and Conduct Sponsored by the ECOG-ACRIN Cancer Research Group Amgen (NASDAQ: AMGN) today announced the ECOG-ACRIN Cancer...(PR Newswire)

Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.13 per share dividend for the first quarter of 2023. The dividend will be paid on March 8, 2023, to all stockholders of record as of the close of business on February 15...(PR Newswire)

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - December 12, 2022) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Horizon Therapeutics plc ("Horizon Therapeutics" or the...(Newsfile)

Weiss Lawis investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Horizon Therapeutics Public Limited Company ("Horizon Therapeutics" or the "Company") (NASDAQ: HZNP) in connection with the...(PR Newswire)

Amgen (NASDAQ:AMGN) will host a webcast call for the investment community following the announced acquisition of Horizon Therapeutics at 8:00 a.m. ET on Monday, December 12, 2022. Robert A. Bradway, chairman and chief executive officer, along with...(PR Newswire)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION (PR Newswire)

AMG 133 is a First-in-Class Investigational Bispecific Molecule That Activates GLP-1R and Inhibits GIPR Phase 1 Results Showed up to 14.5% Reduction in Body Weight at the Highest Dose After 12 Weeks Initiating Phase 2 Study in Early 2023 (PR Newswire)

Amgen (NASDAQ:AMGN) will host a webcast call for the investment community in conjunction with the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) at 8:00 a.m. ET on Monday, Dec. 5, 2022. David M. Reese, M.D...(PR Newswire)

Amgen (NASDAQ:AMGN) will present at the Evercore ISI HealthCONx Conference at 11:20 a.m. ET on Tuesday, November 29, 2022. David M. Reese, M.D., executive vice president of Research and Development at Amgen will present at the conference. The...(PR Newswire)

FN Media Group Presents USA News Group News Commentary Roughly five years after selling its flagship cancer asset Onivyde from to French biotech giant Ipsen S.A. for approximately $1 billion, Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is still...(PR Newswire)